First Header Logo Second Header Logo

Connection

Yusuke Shiozawa to Humans

Back to Details
This is a "connection" page, showing publications Yusuke Shiozawa has written about Humans.
Yusuke Shiozawa
Connection Strength
0.988
Humans
  1. Yu Y, Ollodart J, Contino KF, Shiozawa Y. Immunotherapy as a potential treatment approach for currently incurable bone metastasis. J Bone Miner Metab. 2023 May; 41(3):371-379.
    View in: PubMed
    Score: 0.050
  2. Contino KF, Yadav H, Shiozawa Y. The gut microbiota can be a potential regulator and treatment target of bone metastasis. Biochem Pharmacol. 2022 Mar; 197:114916.
    View in: PubMed
    Score: 0.047
  3. Patel CM, Wadas TJ, Shiozawa Y. Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases. Molecules. 2021 Apr 09; 26(8).
    View in: PubMed
    Score: 0.044
  4. Shiozawa Y. The Roles of Bone Marrow-Resident Cells as a Microenvironment for Bone Metastasis. Adv Exp Med Biol. 2020; 1226:57-72.
    View in: PubMed
    Score: 0.041
  5. Park SH, Eber MR, Shiozawa Y. Models of Prostate Cancer Bone Metastasis. Methods Mol Biol. 2019; 1914:295-308.
    View in: PubMed
    Score: 0.038
  6. Widner DB, Park SH, Eber MR, Shiozawa Y. Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy. Curr Osteoporos Rep. 2018 10; 16(5):596-602.
    View in: PubMed
    Score: 0.037
  7. Park SH, Keller ET, Shiozawa Y. Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis. Calcif Tissue Int. 2018 02; 102(2):152-162.
    View in: PubMed
    Score: 0.035
  8. Tsuzuki S, Park SH, Eber MR, Peters CM, Shiozawa Y. Skeletal complications in cancer patients with bone metastases. Int J Urol. 2016 10; 23(10):825-832.
    View in: PubMed
    Score: 0.032
  9. Shiozawa Y, Berry JE, Eber MR, Jung Y, Yumoto K, Cackowski FC, Yoon HJ, Parsana P, Mehra R, Wang J, McGee S, Lee E, Nagrath S, Pienta KJ, Taichman RS. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer. Oncotarget. 2016 Jul 05; 7(27):41217-41232.
    View in: PubMed
    Score: 0.032
  10. Shiozawa Y, Taichman RS. Bone: Elucidating which cell erythropoietin targets in bone. Nat Rev Endocrinol. 2015 May; 11(5):263-4.
    View in: PubMed
    Score: 0.029
  11. Shiozawa Y, Taichman RS. HSCs and niche relations marked by CD166. Blood. 2014 Jul 24; 124(4):471-2.
    View in: PubMed
    Score: 0.028
  12. Yumoto K, Eber MR, Berry JE, Taichman RS, Shiozawa Y. Molecular pathways: niches in metastatic dormancy. Clin Cancer Res. 2014 Jul 01; 20(13):3384-9.
    View in: PubMed
    Score: 0.027
  13. Yumoto K, Berry JE, Taichman RS, Shiozawa Y. A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiD. Cytometry A. 2014 Jun; 85(6):548-55.
    View in: PubMed
    Score: 0.027
  14. Shiozawa Y, McGee S, Pienta MJ, McGregor N, Jung Y, Yumoto K, Wang J, Berry JE, Pienta KJ, Taichman RS. Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis. J Cell Biochem. 2013 Nov; 114(11):2471-8.
    View in: PubMed
    Score: 0.027
  15. Shiozawa Y, Inuzuka R, Harita Y, Kagawa J. Age-related differences in the course of the acute phase symptoms of Kawasaki disease. Pediatr Infect Dis J. 2013 Sep; 32(9):e365-9.
    View in: PubMed
    Score: 0.026
  16. Shiozawa Y, Nie B, Pienta KJ, Morgan TM, Taichman RS. Cancer stem cells and their role in metastasis. Pharmacol Ther. 2013 May; 138(2):285-93.
    View in: PubMed
    Score: 0.025
  17. Shiozawa Y, Taichman RS, Keller ET. Detection and isolation of human disseminated tumor cells in the murine bone marrow stem cell niche. Methods Mol Biol. 2013; 1035:207-15.
    View in: PubMed
    Score: 0.025
  18. Shiozawa Y, Taichman RS. Getting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche. Exp Hematol. 2012 Sep; 40(9):685-94.
    View in: PubMed
    Score: 0.024
  19. Shiozawa Y, Pienta KJ, Taichman RS. Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors. Clin Cancer Res. 2011 Sep 01; 17(17):5553-8.
    View in: PubMed
    Score: 0.023
  20. Shiozawa Y, Pedersen EA, Havens AM, Jung Y, Mishra A, Joseph J, Kim JK, Patel LR, Ying C, Ziegler AM, Pienta MJ, Song J, Wang J, Loberg RD, Krebsbach PH, Pienta KJ, Taichman RS. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest. 2011 Apr; 121(4):1298-312.
    View in: PubMed
    Score: 0.022
  21. Shiozawa Y, Jung Y, Ziegler AM, Pedersen EA, Wang J, Wang Z, Song J, Wang J, Lee CH, Sud S, Pienta KJ, Krebsbach PH, Taichman RS. Erythropoietin couples hematopoiesis with bone formation. PLoS One. 2010 May 27; 5(5):e10853.
    View in: PubMed
    Score: 0.021
  22. Shiozawa Y, Pedersen EA, Patel LR, Ziegler AM, Havens AM, Jung Y, Wang J, Zalucha S, Loberg RD, Pienta KJ, Taichman RS. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. Neoplasia. 2010 Feb; 12(2):116-27.
    View in: PubMed
    Score: 0.020
  23. Shiozawa Y, Pedersen EA, Taichman RS. GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche. Exp Hematol. 2010 Feb; 38(2):132-40.
    View in: PubMed
    Score: 0.020
  24. Shiozawa Y, Takenouchi H, Taguchi T, Saito M, Katagiri YU, Okita H, Shimizu T, Yamashiro Y, Fujimoto J, Kiyokawa N. Human osteoblasts support hematopoietic cell development in vitro. Acta Haematol. 2008; 120(3):134-45.
    View in: PubMed
    Score: 0.019
  25. Shiozawa Y, Havens AM, Jung Y, Ziegler AM, Pedersen EA, Wang J, Wang J, Lu G, Roodman GD, Loberg RD, Pienta KJ, Taichman RS. Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer. J Cell Biochem. 2008 Oct 01; 105(2):370-80.
    View in: PubMed
    Score: 0.019
  26. Shiozawa Y, Sakaguchi S, Sakakibara O, Yagishita K, Saito M, Yamashiro Y. Urolithiasis in an acute lymphoblastic leukemia child during induction chemotherapy. Pediatr Hematol Oncol. 2008 Jun; 25(4):359-63.
    View in: PubMed
    Score: 0.018
  27. Shiozawa Y, Kiyokawa N, Fujimura J, Suzuki K, Yarita Y, Fujimoto J, Saito M, Yamashiro Y. Primary malignant lymphoma of the central nervous system in an immunocompetent child: a case report. J Pediatr Hematol Oncol. 2005 Oct; 27(10):561-4.
    View in: PubMed
    Score: 0.015
  28. Shiozawa Y, Kiyokawa N, Saito M, Fujimoto J, Hata J, Yamashiro Y. Granulocytic sarcoma of the spine in a child without bone marrow involvement: a case report and literature review. Eur J Pediatr. 2005 Oct; 164(10):616-20.
    View in: PubMed
    Score: 0.015
  29. Shiozawa Y, Fujita H, Fujimura J, Suzuki K, Sato H, Saito M, Shimizu T, Yamashiro Y. A fetal case of transient abnormal myelopoiesis with severe liver failure in Down syndrome: prognostic value of serum markers. Pediatr Hematol Oncol. 2004 Apr-May; 21(3):273-8.
    View in: PubMed
    Score: 0.014
  30. Wu K, Feng J, Lyu F, Xing F, Sharma S, Liu Y, Wu SY, Zhao D, Tyagi A, Deshpande RP, Pei X, Ruiz MG, Takahashi H, Tsuzuki S, Kimura T, Mo YY, Shiozawa Y, Singh R, Watabe K. Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer. Nat Commun. 2021 08 31; 12(1):5196.
    View in: PubMed
    Score: 0.011
  31. Wu SY, Xing F, Sharma S, Wu K, Tyagi A, Liu Y, Zhao D, Deshpande RP, Shiozawa Y, Ahmed T, Zhang W, Chan M, Ruiz J, Lycan TW, Dothard A, Watabe K. Nicotine promotes brain metastasis by polarizing microglia and suppressing innate immune function. J Exp Med. 2020 08 03; 217(8).
    View in: PubMed
    Score: 0.011
  32. Lycan TW, Hsu FC, Ahn CS, Thomas A, Walker FO, Sangueza OP, Shiozawa Y, Park SH, Peters CM, Romero-Sandoval EA, Melin SA, Sorscher S, Ansley K, Lesser GJ, Cartwright MS, Strowd RE. Neuromuscular ultrasound for taxane peripheral neuropathy in breast cancer. Muscle Nerve. 2020 05; 61(5):587-594.
    View in: PubMed
    Score: 0.010
  33. Cackowski FC, Eber MR, Rhee J, Decker AM, Yumoto K, Berry JE, Lee E, Shiozawa Y, Jung Y, Aguirre-Ghiso JA, Taichman RS. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy. J Cell Biochem. 2017 04; 118(4):891-902.
    View in: PubMed
    Score: 0.008
  34. Sharma S, Xing F, Liu Y, Wu K, Said N, Pochampally R, Shiozawa Y, Lin HK, Balaji KC, Watabe K. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone. J Biol Chem. 2016 09 09; 291(37):19351-63.
    View in: PubMed
    Score: 0.008
  35. Seib FP, Berry JE, Shiozawa Y, Taichman RS, Kaplan DL. Tissue engineering a surrogate niche for metastatic cancer cells. Biomaterials. 2015 May; 51:313-319.
    View in: PubMed
    Score: 0.007
  36. Jung Y, Wang J, Lee E, McGee S, Berry JE, Yumoto K, Dai J, Keller ET, Shiozawa Y, Taichman RS. Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow. Mol Cancer Res. 2015 Jan; 13(1):197-207.
    View in: PubMed
    Score: 0.007
  37. Havens AM, Sun H, Shiozawa Y, Jung Y, Wang J, Mishra A, Jiang Y, O'Neill DW, Krebsbach PH, Rodgerson DO, Taichman RS. Human and murine very small embryonic-like cells represent multipotent tissue progenitors, in vitro and in vivo. Stem Cells Dev. 2014 Apr 01; 23(7):689-701.
    View in: PubMed
    Score: 0.007
  38. Kim JK, Jung Y, Wang J, Joseph J, Mishra A, Hill EE, Krebsbach PH, Pienta KJ, Shiozawa Y, Taichman RS. TBK1 regulates prostate cancer dormancy through mTOR inhibition. Neoplasia. 2013 Sep; 15(9):1064-74.
    View in: PubMed
    Score: 0.007
  39. Taichman RS, Patel LR, Bedenis R, Wang J, Weidner S, Schumann T, Yumoto K, Berry JE, Shiozawa Y, Pienta KJ. GAS6 receptor status is associated with dormancy and bone metastatic tumor formation. PLoS One. 2013; 8(4):e61873.
    View in: PubMed
    Score: 0.006
  40. Jung Y, Kim JK, Shiozawa Y, Wang J, Mishra A, Joseph J, Berry JE, McGee S, Lee E, Sun H, Wang J, Jin T, Zhang H, Dai J, Krebsbach PH, Keller ET, Pienta KJ, Taichman RS. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun. 2013; 4:1795.
    View in: PubMed
    Score: 0.006
  41. Havens AM, Shiozawa Y, Jung Y, Sun H, Wang J, McGee S, Mishra A, Taichman LS, Danciu T, Jiang Y, Yavanian G, Leary E, Krebsbach PH, Rodgerson D, Taichman RS. Human very small embryonic-like cells generate skeletal structures, in vivo. Stem Cells Dev. 2013 Feb 15; 22(4):622-30.
    View in: PubMed
    Score: 0.006
  42. Jung Y, Shiozawa Y, Wang J, McGregor N, Dai J, Park SI, Berry JE, Havens AM, Joseph J, Kim JK, Patel L, Carmeliet P, Daignault S, Keller ET, McCauley LK, Pienta KJ, Taichman RS. Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment. Neoplasia. 2012 May; 14(5):429-39.
    View in: PubMed
    Score: 0.006
  43. Mishra A, Wang J, Shiozawa Y, McGee S, Kim J, Jung Y, Joseph J, Berry JE, Havens A, Pienta KJ, Taichman RS. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer. Mol Cancer Res. 2012 Jun; 10(6):703-12.
    View in: PubMed
    Score: 0.006
  44. Pedersen EA, Shiozawa Y, Pienta KJ, Taichman RS. The prostate cancer bone marrow niche: more than just 'fertile soil'. Asian J Androl. 2012 May; 14(3):423-7.
    View in: PubMed
    Score: 0.006
  45. Joseph J, Shiozawa Y, Jung Y, Kim JK, Pedersen E, Mishra A, Zalucha JL, Wang J, Keller ET, Pienta KJ, Taichman RS. Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype. Mol Cancer Res. 2012 Mar; 10(3):282-92.
    View in: PubMed
    Score: 0.006
  46. D'Souza S, Kurihara N, Shiozawa Y, Joseph J, Taichman R, Galson DL, Roodman GD. Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment. Blood. 2012 Feb 23; 119(8):1888-96.
    View in: PubMed
    Score: 0.006
  47. Kim J, Jung Y, Sun H, Joseph J, Mishra A, Shiozawa Y, Wang J, Krebsbach PH, Taichman RS. Erythropoietin mediated bone formation is regulated by mTOR signaling. J Cell Biochem. 2012 Jan; 113(1):220-8.
    View in: PubMed
    Score: 0.006
  48. Pedersen EA, Shiozawa Y, Mishra A, Taichman RS. Structure and function of the solid tumor niche. Front Biosci (Schol Ed). 2012 Jan 01; 4:1-15.
    View in: PubMed
    Score: 0.006
  49. Yu C, Shiozawa Y, Taichman RS, McCauley LK, Pienta K, Keller E. Prostate cancer and parasitism of the bone hematopoietic stem cell niche. Crit Rev Eukaryot Gene Expr. 2012; 22(2):131-48.
    View in: PubMed
    Score: 0.006
  50. Patel LR, Camacho DF, Shiozawa Y, Pienta KJ, Taichman RS. Mechanisms of cancer cell metastasis to the bone: a multistep process. Future Oncol. 2011 Nov; 7(11):1285-97.
    View in: PubMed
    Score: 0.006
  51. Jung Y, Shiozawa Y, Wang J, Wang J, Wang Z, Pedersen EA, Lee CH, Hall CL, Hogg PJ, Krebsbach PH, Keller ET, Taichman RS. Expression of PGK1 by prostate cancer cells induces bone formation. Mol Cancer Res. 2009 Oct; 7(10):1595-604.
    View in: PubMed
    Score: 0.005
  52. Sun YX, Pedersen EA, Shiozawa Y, Havens AM, Jung Y, Wang J, Pienta KJ, Taichman RS. CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12. Clin Exp Metastasis. 2008; 25(7):765-76.
    View in: PubMed
    Score: 0.005
  53. Havens AM, Chiu E, Taba M, Wang J, Shiozawa Y, Jung Y, Taichman LS, D'Silva NJ, Gopalakrishnan R, Wang C, Giannobile WV, Taichman RS. Stromal-derived factor-1alpha (CXCL12) levels increase in periodontal disease. J Periodontol. 2008 May; 79(5):845-53.
    View in: PubMed
    Score: 0.005
  54. Havens AM, Pedersen EA, Shiozawa Y, Ying C, Jung Y, Sun Y, Neeley C, Wang J, Mehra R, Keller ET, McCauley LK, Loberg RD, Pienta KJ, Taichman RS. An in vivo mouse model for human prostate cancer metastasis. Neoplasia. 2008 Apr; 10(4):371-80.
    View in: PubMed
    Score: 0.005
  55. Wang J, Shiozawa Y, Wang J, Wang Y, Jung Y, Pienta KJ, Mehra R, Loberg R, Taichman RS. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem. 2008 Feb 15; 283(7):4283-94.
    View in: PubMed
    Score: 0.004
  56. Taguchi T, Takenouchi H, Shiozawa Y, Matsui J, Kitamura N, Miyagawa Y, Katagiri YU, Takahashi T, Okita H, Fujimoto J, Kiyokawa N. Interleukin-7 contributes to human pro-B-cell development in a mouse stromal cell-dependent culture system. Exp Hematol. 2007 Sep; 35(9):1398-407.
    View in: PubMed
    Score: 0.004
  57. Taguchi T, Takenouchi H, Matsui J, Tang WR, Itagaki M, Shiozawa Y, Suzuki K, Sakaguchi S, Ktagiri YU, Takahashi T, Okita H, Fujimoto J, Kiyokawa N. Involvement of insulin-like growth factor-I and insulin-like growth factor binding proteins in pro-B-cell development. Exp Hematol. 2006 Apr; 34(4):508-18.
    View in: PubMed
    Score: 0.004
  58. Matsui J, Kiyokawa N, Takenouchi H, Taguchi T, Suzuki K, Shiozawa Y, Saito M, Tang WR, Katagiri YU, Okita H, Fujimoto J. Dietary bioflavonoids induce apoptosis in human leukemia cells. Leuk Res. 2005 May; 29(5):573-81.
    View in: PubMed
    Score: 0.004
  59. Taguchi T, Kiyokawa N, Takenouch H, Matsui J, Tang WR, Nakajima H, Suzuki K, Shiozawa Y, Saito M, Katagiri YU, Takahashi T, Karasuyama H, Matsuo Y, Okita H, Fujimoto J. Deficiency of BLNK hampers PLC-gamma2 phosphorylation and Ca2+ influx induced by the pre-B-cell receptor in human pre-B cells. Immunology. 2004 Aug; 112(4):575-82.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.